Fast Locator 2012-2013: DPT Laboratories - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

Fast Locator 2012-2013: DPT Laboratories

DPT is a contract development and manufacturing organization (CDMO) specializing in sterile and non-sterile semi-solid and liquid dosage forms. DPT provides fully integrated development, manufacturing and packaging solutions for biopharmaceutical and pharmaceutical products. DPT is the source for semi-solid and liquids — from concept to commercialization and beyond.

Drug development services range from pre-formulation, formulation and biopharmaceutical development, analytical development and validation, through process development.

Production capabilities include five cGMP facilities, clinical trial materials, full scale commercial production, controlled substance registration Class II – IV, and complete supply chain management.

Packaging services encompass engineering and procurement resources necessary for conventional and specialized packaging.



blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
View Results
Eric Langerr Outsourcing Outlook Eric LangerTargeting Different Off-Shore Destinations
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAsymmetric Synthesis Continues to Advance
Jill Wechsler Regulatory Watch Jill Wechsler Data Integrity Key to GMP Compliance
Sean Milmo European Regulatory WatchSean MilmoExtending the Scope of Pharmacovigilance Comes at a Price
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes

Click here